Annalise Enterprise CXR Triage Trauma is an AI-enabled medical device from Annalise-AI Pty Ltd, listed by FDA (510(k), K222179) with a decision date of 2023-03-28. Review panel: Radiology.
| FDA submission number | K222179 |
|---|---|
| Pathway | 510(k) |
| Company | Annalise-AI Pty Ltd |
| Review panel (specialty) | Radiology |
| FDA decision date | 2023-03-28 |
| Decision | Substantially Equivalent |
| Product code | QFM |
| Classification | Radiological Computer-Assisted Prioritization Software For Lesions |
| Device class | 2 |
| Regulation number | 892.2080 |
| Review time (calendar days) | 249 |
| Applicant country | AU |
Official FDA database record · FDA AI-enabled device list
More devices from Annalise-AI Pty Ltd · All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.